Acute intermittent porphyria

Also known as:
Porphyria
Acute intermittent porphyria

Last modified: 5th February 2023


Strong association with:
Acute porphyric crisis

Implicated drugs:

Ergometrine

Hydralazine

Methyldopa

Pentobarbital

Phenytoin

Thiopentone

Potentially implicated drugs:

Etomidate

Halothane

Ketamine

Attacks manifest as severe abdominal pain, vomiting, anxiety, confusion, autonomic instability, dehydration and electrolyte disturbances.

Progressive neuropathy is thought to be a consequence of direct ALA neurotoxicity or diminished intraneuronal heme.

Drug triggers

Thiopental

The majority of described drug-precipitated attacks have been associated with thiopental. Not every administration results in a porphyric crisis.

Benodiazepines

Diazepam has been implicated as a trigger, though it has also been used safely

Ketamine

Has been implicated as a trigger, though possibly only at high, supratherapeutic levels

Halothane

Historical reports of an association with halothane have not been borne out in clinical experience


Drugs with a history of safety in porphyria

  • Propofol
  • Suxamethonium
  • Vecuronium, pancuronium
  • Atracurium
  • Bupivucaine
  • Volatile anaesthetics (other than halothane)
An update of clinical management of acute intermittent porphyria

The Application of Clinical Genetics 2015

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/
The Drug Database for Acute Porphyria

Porphyria Centre Sweden

http://drugs-porphyria.org